Prognostic Factors for Long-term Aesthetic Outcome of Infantile Haemangioma Treated with Beta-blockers

Authors

  • Mireille M. Hermans Erasmus MC Sophia Children’s Hospital, University Medical Center Rotterdam, Department of Dermatology – Center of Pediatric Dermatology, Center of Rare Skin Diseases, Vascular Anomaly Center Erasmus MC Rotterdam, member of the ERN-SKIN-Mosaic group and ERN-VASCERN-VASCA group, The Netherlands
  • Suzanne G.M.A. Pasmans Erasmus MC Sophia Children’s Hospital, University Medical Center Rotterdam, Department of Dermatology – Center of Pediatric Dermatology, Center of Rare Skin Diseases, Vascular Anomaly Center Erasmus MC Rotterdam, member of the ERN-SKIN-Mosaic group and ERN-VASCERN-VASCA group, The Netherlands
  • Marlies de Graaf Department of Dermatology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, UMC Utrecht Center for Vascular Anomalies, The Netherlands
  • Aviël Ragamin Erasmus MC Sophia Children’s Hospital, University Medical Center Rotterdam, Department of Dermatology – Center of Pediatric Dermatology, Center of Rare Skin Diseases, Vascular Anomaly Center Erasmus MC Rotterdam, member of the ERN-SKIN-Mosaic group and ERN-VASCERN-VASCA group, The Netherlands
  • Elodie J. Mendels Erasmus MC Sophia Children’s Hospital, University Medical Center Rotterdam, Department of Dermatology – Center of Pediatric Dermatology, Center of Rare Skin Diseases, Vascular Anomaly Center Erasmus MC Rotterdam, member of the ERN-SKIN-Mosaic group and ERN-VASCERN-VASCA group, The Netherlands
  • Johannes M.P.J. Breur Department of Pediatric Cardiology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, The Netherlands
  • Hester R. Langeveld Erasmus MC Sophia Children’s Hospital, University Medical Center Rotterdam, Department of Intensive Care and Pediatric Surgery, Center of Rare Skin Diseases, Vascular Anomaly Center Erasmus MC Rotterdam, member of the ERN-SKIN-Mosaic group and ERN-VASCERN-VASCA group, The Netherlands
  • Martine F. Raphael Department of Dermatology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, UMC Utrecht Center for Vascular Anomalies, The Netherlands
  • Peter C.J. de Laat Erasmus MC Sophia Children’s Hospital, University Medical Center Rotterdam, Department of Pediatrics (-Hemato-oncology), Center of Rare Skin Diseases, Vascular Anomaly Center Erasmus MC Rotterdam, member of the ERN-SKIN-Mosaic group and ERN-VASCERN-VASCA group, The Netherlands
  • Saskia N. de Wildt Department of Pharmacology and Toxicology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands
  • André B. Rietman Erasmus MC Sophia Children’s Hospital, University Medical Center Rotterdam, Department of Child and Adolescent Psychology/Psychiatry, the Netherlands
  • Corstiaan C. Breugem Department of Plastic Surgery, Wilhelmina Children’s Hospital, University Medical Center Utrecht, UMC Utrecht Center for Vascular Anomalies, The Netherlands
  • Renske Schappin Department of Surgery, Wilhelmina Children’s Hospital, University Medical Center Utrecht, the Netherlands

DOI:

https://doi.org/10.2340/actadv.v103.5286

Keywords:

Vascular tissue neoplasms, Adrenergic beta-antagonists, Infant, Esthetics, Cicatrix, Telangiectasis

Abstract

Parents of infants treated with beta-blockers for infantile haemangioma are often concerned about the long-term aesthetic outcome. This cross-sectional study assessed the influence on the long-term aesthetic outcome of characteristics of the infantile haemangioma, the beta-blocker treatment, and the infant. The study included 103 children aged 6–12 years, treated with beta-blockers (propranolol or atenolol) for infantile haemangioma during infancy (age at treatment initiation ≤1 year) for ≥6 months. Dermatologists and parents scored the Patient Observer Scar Assessment Scale, and the child scored a visual analogue scale. Dermatologists identified whether telangiectasia, fibrofatty tissue, and atrophic scar tissue were present. The long-term aesthetic outcome of infantile haemangioma was judged more negatively by dermatologists and parents in case of a superficial component, ulceration, older age at treatment initiation, higher cumulative dose, and/or shorter follow-up time. According to children, infantile haemangioma located on the head had better aesthetic outcome than infantile haemangioma located elsewhere. Close monitoring, particularly of infantile haemangioma with a superficial component, is essential for early initiation of treatment, and to prevent or treat ulceration. These outcome data can support parental counselling and guide treatment strategy.

Downloads

Download data is not yet available.

Author Biographies

Suzanne G.M.A. Pasmans, Erasmus MC Sophia Children’s Hospital, University Medical Center Rotterdam, Department of Dermatology – Center of Pediatric Dermatology, Center of Rare Skin Diseases, Vascular Anomaly Center Erasmus MC Rotterdam, member of the ERN-SKIN-Mosaic group and ERN-VASCERN-VASCA group, The Netherlands

Suzanne G.M.A. Pasmans and Marlies de Graaf contributed equally as co-second authors. 

Marlies de Graaf, Department of Dermatology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, UMC Utrecht Center for Vascular Anomalies, The Netherlands

Suzanne G.M.A. Pasmans and Marlies de Graaf contributed equally as co-second authors.

Martine F. Raphael, Department of Dermatology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, UMC Utrecht Center for Vascular Anomalies, The Netherlands

Current affiliation: Department Emma Children’s Hospital, Amsterdam UMC Location University of Amsterdam, The Netherlands

Corstiaan C. Breugem, Department of Plastic Surgery, Wilhelmina Children’s Hospital, University Medical Center Utrecht, UMC Utrecht Center for Vascular Anomalies, The Netherlands

Corstiaan C. Breugem and Renske Schappin contributed equally as co-last authors.

Current affiliation: Department of Plastic, Reconstructive and Hand Surgery, Amsterdam UMC, University of Amsterdam, The Netherlands

Renske Schappin, Department of Surgery, Wilhelmina Children’s Hospital, University Medical Center Utrecht, the Netherlands

Corstiaan C. Breugem and Renske Schappin contributed equally as co-last authors.

Current affiliation: Erasmus MC Sophia Children’s Hospital, University Medical Center Rotterdam, Department of Dermatology – Center of Pediatric Dermatology, Center of Rare Skin Diseases, Vascular Anomaly Center Erasmus MC Rotterdam, member of the ERN-SKIN-Mosaic group and ERN-VASCERN-VASCA group, The Netherlands

References

Anderson KR, Schoch JJ, Lohse CM, Hand JL, Davis DM, Tollefson MM. Increasing incidence of infantile hemangiomas (IH) over the past 35 years: correlation with decreasing gestational age at birth and birth weight. J Am Acad Dermatol 2016; 74: 120-126.

https://doi.org/10.1016/j.jaad.2015.08.024 DOI: https://doi.org/10.1016/j.jaad.2015.08.024

Dickison P, Christou E, Wargon O. A prospective study of infantile hemangiomas with a focus on incidence and risk factors. Pediatr Dermatol 2011; 28: 663-669.

https://doi.org/10.1111/j.1525-1470.2011.01568.x DOI: https://doi.org/10.1111/j.1525-1470.2011.01568.x

Munden A, Butschek R, Tom WL, Marshall JS, Poeltler DM, Krohne SE, et al. Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies. Br J Dermatol 2014; 170: 907-913.

https://doi.org/10.1111/bjd.12804 DOI: https://doi.org/10.1111/bjd.12804

Bauland CG, Lüning TH, Smit JM, Zeebregts CJ, Spauwen PH. Untreated hemangiomas: growth pattern and residual lesions. Plast Reconstr Surg 2011; 127: 1643-1648.

https://doi.org/10.1097/PRS.0b013e318208d2ac DOI: https://doi.org/10.1097/PRS.0b013e318208d2ac

Chang LC, Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC, et al. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 2008; 122: 360-367.

https://doi.org/10.1542/peds.2007-2767 DOI: https://doi.org/10.1542/peds.2007-2767

Couto RA, Maclellan RA, Zurakowski D, Greene AK. Infantile hemangioma: clinical assessment of the involuting phase and implications for management. Plast Reconstr Surg 2012; 130: 619-624.

https://doi.org/10.1097/PRS.0b013e31825dc129 DOI: https://doi.org/10.1097/PRS.0b013e31825dc129

Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC, Horii KA, et al. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics 2006; 118: 882-887.

https://doi.org/10.1542/peds.2006-0413 DOI: https://doi.org/10.1542/peds.2006-0413

Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358: 2649-2651.

https://doi.org/10.1056/NEJMc0708819 DOI: https://doi.org/10.1056/NEJMc0708819

Ji Y, Chen S, Yang K, Zhang X, Zhou J, Li L, et al. Efficacy and safety of propranolol vs atenolol in infants with problematic infantile hemangiomas: a randomized clinical trial. JAMA Otolaryngol Head Neck Surg 2021; 147: 599-607.

https://doi.org/10.1001/jamaoto.2021.0454 DOI: https://doi.org/10.1001/jamaoto.2021.0454

Liu Z, Wu C, Song D, Wang L, Li J, Wang C, et al. Atenolol vs. propranolol for the treatment of infantile haemangiomas: a systematic review and meta-analysis. Exp Ther Med 2020; 20: 1644-1652.

https://doi.org/10.3892/etm.2020.8842 DOI: https://doi.org/10.3892/etm.2020.8842

Yu Z, Cai R, Chang L, Qiu Y, Chen X, Chen Q, et al. Clinical and radiological outcomes of infantile hemangioma treated with oral propranolol: a long-term follow-up study. J Dermatol 2019; 46: 376-382.

https://doi.org/10.1111/1346-8138.14853 DOI: https://doi.org/10.1111/1346-8138.14853

Dieterich-Miller CA, Cohen BA, Liggett J. Behavioral adjustment and self-concept of young children with hemangiomas. Pediatr Dermatol 1992; 9: 241-245.

https://doi.org/10.1111/j.1525-1470.1992.tb00339.x DOI: https://doi.org/10.1111/j.1525-1470.1992.tb00339.x

Hermans MM, Breugem CC, Schappin R, Jonge Poerink E, Mendels EJ, Ragamin A, et al. Aesthetic outcome of propranolol vs atenolol treatment of children with infantile haemangioma. Acta Derm Venereol 2022; 102: adv00788.

https://doi.org/10.2340/actadv.v102.2021 DOI: https://doi.org/10.2340/actadv.v102.2021

Chang SJ, Yu W, Gu Y, Han Y, Shang Y, Chang L, et al. Location of infantile hemangioma is a predictor of volumetric sequelae after involution. J Dermatol 2019; 46: 371-375.

https://doi.org/10.1111/1346-8138.14847 DOI: https://doi.org/10.1111/1346-8138.14847

Chang SJ, Qiao C, Chang L, Gao W, Jin Y, Ma G, et al. A 7-year follow-up study on untreated deep or mixed facial infantile hemangioma in East-Asian patients: when propranolol was not yet an option. J Dermatol 2019; 46: 962-966.

https://doi.org/10.1111/1346-8138.15080 DOI: https://doi.org/10.1111/1346-8138.15080

Baselga E, Roe E, Coulie J, Munoz FZ, Boon LM, McCuaig C, et al. Risk factors for degree and type of sequelae after involution of untreated hemangiomas of infancy. JAMA Dermatol 2016; 152: 1239-1243.

https://doi.org/10.1001/jamadermatol.2016.2905 DOI: https://doi.org/10.1001/jamadermatol.2016.2905

Goldenberg DC, Hiraki PY, Marques TM, Koga A, Gemperli R. Surgical treatment of facial infantile hemangiomas: an analysis based on tumor characteristics and outcomes. Plast Reconstr Surg 2016; 137: 1221-1231.

https://doi.org/10.1097/PRS.0000000000002016 DOI: https://doi.org/10.1097/PRS.0000000000002016

Yuzuriha S, Nagai F, Noguchi M. How to manage disfiguring scars in involuted infantile hemangioma. Adv Wound Care (New Rochelle) 2019; 8: 221-229.

https://doi.org/10.1089/wound.2018.0847 DOI: https://doi.org/10.1089/wound.2018.0847

Hermans MM, Rietman AB, Schappin R, de Laat PCJ, Mendels EJ, Breur JMPJ, et al. Long-term neurocognitive functioning of children treated with propranolol or atenolol for infantile hemangioma. Eur J Pediatr 2023; 182: 757-767.

https://doi.org/10.1007/s00431-022-04674-7 DOI: https://doi.org/10.1007/s00431-022-04674-7

van de Kar AL, Corion LU, Smeulders MJ, Draaijers LJ, van der Horst CM, van Zuijlen PP. Reliable and feasible evaluation of linear scars by the Patient and Observer Scar Assessment Scale. Plast Reconstr Surg 2005; 116: 514-522.

https://doi.org/10.1097/01.prs.0000172982.43599.d6 DOI: https://doi.org/10.1097/01.prs.0000172982.43599.d6

UMC Utrecht Wilhelmina Kinderziekenhuis. Faces pain scale. [cited 2021 Jul 14] Available from: https://www.hetwkz-kind.nl/obzf/narcose-na-de-ingreep-pijn/pijnliniaaljpg/.

Tomlinson D, von Baeyer CL, Stinson JN, Sung L. A systematic review of faces scales for the self-report of pain intensity in children. Pediatrics 2010; 126: e1168-1198.

https://doi.org/10.1542/peds.2010-1609 DOI: https://doi.org/10.1542/peds.2010-1609

Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988; 124: 869-871. DOI: https://doi.org/10.1001/archderm.124.6.869

https://doi.org/10.1001/archderm.1988.01670060015008 DOI: https://doi.org/10.1001/archderm.1988.01670060015008

Nederlandse Vereniging voor Dermatologie en Venereologie (NVDV). Infantiele Hemangiomen Richtlijn 2021. [cited 2022 Nov 11] Available from: https://www.nvpc.nl/uploads/stand/212NVDV%20Richtlijn%20Infantiele%20Hemangiomen%202021.pdf.

Krowchuk DP, Frieden IJ, Mancini AJ, Darrow DH, Blei F, Greene AK, et al. Clinical practice guideline for the management of infantile hemangiomas. Pediatrics 2019; 143: e20183475.

https://doi.org/10.1542/peds.2018-3475 DOI: https://doi.org/10.1542/peds.2018-3475

International Society for the Study of Vascular Anomalies (ISSVA). ISSVA Classification of Vascular Anomalies ©2018. [cited 2022 Nov 11] Available from: https://www.issva.org/classification.

Organisation for Economic Co-operation and Development (OECD), European Union, UNESCO Institute for Statistics. ISCED 2011 Operational Manual: Guidelines for Classifying National Education Programmes and Related Qualifications. [cited 2022 Nov 11] Available from http://dx.doi.org/10.1787/9789264228368-en.

https://doi.org/10.1787/9789264228368-en DOI: https://doi.org/10.1787/9789264228368-en

Mathes T, Jaschinski T, Pieper D. Adherence influencing factors - a systematic review of systematic reviews. Arch Public Health 2014; 72: 37.

https://doi.org/10.1186/2049-3258-72-37 DOI: https://doi.org/10.1186/2049-3258-72-37

RStudio Team. RStudio: integrated development for R. Boston, MA: RStudio, 2020.

Sagi L, Zvulunov A, Lapidoth M, Ben Amitai D. Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases. Dermatology 2014; 228: 136-144.

https://doi.org/10.1159/000351557 DOI: https://doi.org/10.1159/000351557

Yildirimcakar D, Demirsoy U, Azizoglu M, Corapcioglu F. Evaluation of clinical properties and treatment responses of infantile hemangioma. J Drugs Dermatol 2020; 19: 1156-1165.

https://doi.org/10.36849/JDD.2020.5009 DOI: https://doi.org/10.36849/JDD.2020.5009

Al-Mayoof AF, Joda AE, Almushhadany OE. Propranolol therapy in infantile hemangioma: correlation of age and duration of treatment to the outcomes. Ann Pediatr Surg 2019; 15: 8.

https://doi.org/10.1186/s43159-019-0007-7 DOI: https://doi.org/10.1186/s43159-019-0007-7

Hoornweg MJ, Smeulders MJC, Ubbink DT, van der Horst CMAM. The prevalence and risk factors of infantile haemangiomas: a case-control study in the Dutch population. Paediatr Perinat Epidemiol 2012; 26: 156-162.

https://doi.org/10.1111/j.1365-3016.2011.01214.x DOI: https://doi.org/10.1111/j.1365-3016.2011.01214.x

Dao H, Kazin RA. Gender differences in skin: a review of the literature. Gend Med 2007; 4: 308-328.

https://doi.org/10.1016/S1550-8579(07)80061-1 DOI: https://doi.org/10.1016/S1550-8579(07)80061-1

Engeland CG, Bosch JA, Cacioppo JT, Marucha PT. Mucosal wound healing: the roles of age and sex. Arch Surg 2006; 141: 1193-1197.

https://doi.org/10.1001/archsurg.141.12.1193 DOI: https://doi.org/10.1001/archsurg.141.12.1193

Moss TP. The relationships between objective and subjective ratings of disfigurement severity, and psychological adjustment. Body Image 2005; 2: 151-159.

https://doi.org/10.1016/j.bodyim.2005.03.004 DOI: https://doi.org/10.1016/j.bodyim.2005.03.004

Haggstrom AN, Lammer EJ, Schneider RA, Marcucio R, Frieden IJ. Patterns of infantile hemangiomas: new clues to hemangioma pathogenesis and embryonic facial development. Pediatrics 2006; 117: 698-703.

https://doi.org/10.1542/peds.2005-1092 DOI: https://doi.org/10.1542/peds.2005-1092

Riley AW. Evidence that school-age children can self-report on their health. Ambul Pediatr 2004; 4: 371-376.

https://doi.org/10.1367/A03-178R.1 DOI: https://doi.org/10.1367/A03-178R.1

Smolak L. Appearance in childhood and adolescence. The Oxford handbook of the psychology of appearance. New York, NY: Oxford University Press; 2012: p. 123-141.

https://doi.org/10.1093/oxfordhb/9780199580521.013.0013 DOI: https://doi.org/10.1093/oxfordhb/9780199580521.013.0013

Downloads

Published

2023-08-30

How to Cite

Hermans, M. M. ., Pasmans, S. G., de Graaf, M., Ragamin, A., Mendels, E. J., Breur, J. M., Langeveld, H. R., Raphael, M. F., de Laat, P. C., de Wildt, S. N., Rietman, A. B., Breugem, C. C., & Schappin, R. (2023). Prognostic Factors for Long-term Aesthetic Outcome of Infantile Haemangioma Treated with Beta-blockers. Acta Dermato-Venereologica, 103, adv5286. https://doi.org/10.2340/actadv.v103.5286

Issue

Vol. 103 (2023)

Section

Articles

Categories

License

Copyright (c) 2023 Mireille M. Hermans, Suzanne G.M.A. Pasmans, Marlies de Graaf, Aviël Ragamin, Elodie J. Mendels, Johannes M.P.J. Breur, Hester R. Langeveld, Martine F. Raphael, Peter C.J. de Laat, Saskia N. de Wildt, André B. Rietman, Corstiaan C. Breugem, Renske Schappin

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.

Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.

Crossref
Scopus
Google Scholar
Europe PMC